Navigation Links
Acanthamoeba Culture

ProductsAcanthamoeba Culture
Company ARUP Laboratories
Item Acanthamoeba Culture
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Acanthamoeba Stain
2. Culture Incubator
3. Pathfinder Chlamydia Culture Confirmation Test
4. E. Coli Enrichment Culture Strip
5. E. Coli Enrichment Culture Cassette
6. Abscess Culture
7. Actinomyces Culture
8. Adenovirus Culture
9. AFB Culture (Includes AFB Stain 0060151)
10. AFB Culture, Blood
11. Anaerobe Culture (Includes Gram Stain 0060101)
Ballard trach care HMES and filters, tv 1500, HME with built-in flex tube
Indications For Usage: , ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hou
Indications For Usage:, ,Single use on tracheostomy patients who can breathe spontaneously. The product is intended to be replaced at least once every 24 hours.
...eg; Thermovent® T helps provide protection to ... is small and extremely lightweight making it idea...h a high rate of heat and moisture recovery, it en...ion., ,All HMEs and filters have ISO standard tap...
Medicine Products:
(Date:9/5/2008)...RNewswire/ -- On Saturday, September 6, PARI,Respi...twork show Today,s,Family as part of their "Breath... medical device company that provides patients, su...d compressors that deliver needed,medications dire... lives of those affected by respiratory,diseases a...
(Date:9/5/2008)...r those overweight or obese at age 45 , ,...of all American adults will develop osteoarthritis... they are obese in middle age, a new study says. ...on increased as his or her body-mass index (BMI) r... at Chapel Hill study. People who were of normal w...
(Date:9/5/2008)...ediction models are enhanced by taking into accoun... capacity, according to research teams led by epid...son Cancer Center in two complementary papers appe... Research . , In the first study to focus on Afr...ased on increased exposure to certain risks. Based...
(Date:9/4/2008)...2008Private Medicare Advantage (MA) plans will be ...2008 compared to what the same enrollee would have...program, according to a new report from The Common... plans mandated by the Medicare Improvements for P...ed to take effect beginning in 2010 had been full...
Breaking Medicine News(10 mins):Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2
... they want to investigate the case of a British ma...s, reports BBC. // Two Sunday newspapers report Sc...iagnosed as HIV-positive in 2002, but found to be ...lsea and Westminster Healthcare NHS Trust, which c...
...po and researchers have found that the habit of be...n to families making it a genetic character. Resea...oin a group which has more social character people...in 8,000 pairs of twins and found that 50 percent ...
...hrough, which could eventually lead to a practical...s, scientists from the US National Cancer Institut... human body to produce chemicals that block HIV in...urs on the surfaces of the gut and reproductive ar...
...h Minister Anbumani Ramadoss on Saturday urged the...n and modernisation of the 80-year-old Communicabl...hennai.// After a visit to the cholera wards in t... that though the doctors in the CDH had been succe...
Other Medicine News:Health News:British man 'Recovered from HIV' 2Health News:Genetically modified bacteria to combat HIV 2Health News:Diligence Of Chennai Doctors Appreciated: Anbumani 2
(Date:9/5/2008)... VIENNA, Va., Sept. 5 /...y that it presented new rheumatoid arthritis data,...n Amsterdam. The data,presented by Dr. Daniel Zim...r Immunology of CEL-SCI, indicate that CEL-SCI,s r...etards the permanent tissue damage,caused by rheum...
(Date:9/5/2008)... MORGANTOWN, W.Va., Sept. 5 /PRNewswire-USNews...iversity has shown that U.S. immigrants from,India...country, increasing,their risks of prostate cancer...ales., "Breast cancer and prostate cancer develop...d lifestyle play a major role in these cancers,",s...
(Date:9/4/2008)... MELBOURNE, Australia, Sept. 4 /-...t is commencing enrolment for its Phase Ib/II,stud...ng anticancer agent,in patients with an aggressiv...forme (GBM)., The GBM clinical trial is the first... tumor indications for the company and the second ...
(Date:9/4/2008)... SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstC...ay announced that the pivotal clinical study of,Po...,s partner, Chemische,Fabrik KREUSSLER & Co. GmbH ...dpoint and has been submitted to FDA as part of a ...al clinical study, named the EASI (Efficacy and sa...
Breaking Medicine Technology:Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 1Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 2Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 3Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 4Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 5BMI criteria for obesity surgery should be lowered UT Southwestern researcher suggests 1635 1BMI criteria for obesity surgery should be lowered UT Southwestern researcher suggests 1635 2California Breakthrough a Pivotal Moment in Fight to Transform Nations Health Care System 8432 1California Breakthrough a Pivotal Moment in Fight to Transform Nations Health Care System 8432 2GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine 8429 1GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine 8429 2GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine 8429 3
...hering-Plough Corp. announced results,from a Phase...th,Caelyx (pegylated liposomal doxorubicin hydroch...n (TTP) in patients with,metastatic breast cancer ...fter first-line chemotherapy. These data were pres...ican Society of,Clinical Oncology. , ,"While stand...
...est Ever Phase III Clinical Trial in,Lung Cancer T...FirstCall/ --,GlaxoSmithKline today announced fina...trial of its investigational MAGE-A3,Antigen-Speci...itive patients with stage IB or II Non-Small Cell ...the 2007 American Society of,Clinical Oncology (AS...
Other Medicine Technology:Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 2Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 3Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 4Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 5Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 2Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 3Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 4Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 5Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 6